Page 92 - 2022 Ranger Medic Handbook
P. 92

CBRN – Nerve Agents
         Nerve agents are considered the primary agents of threat to the US military because of their high toxicity and effective-
         ness through multiple routes of entry. They are absorbed through the eyes, respiratory tract, and skin. Nerve agents are
         generally referred to a group of chemicals known as organophosphates. These compounds inhibit acetylcholinesterase
         (AChE) thus having acetylcholine (ACh) accumulating in the body causing multiple organ overstimulation. This produces
         a cholinergic crisis from the excessive amounts of ACH: Muscarinic effects of smooth muscle contraction in airways,
    SECTION 2  causing bradycardia; nicotinic effects of skeletal muscles with fasciculations seizures, fatigue, and flaccid paralysis (late
         GI tract, pupils (miosis); glandular effects from eyes, nose, mouth, sweat, airways and GI tract; effect on vagus nerve
         sign); preganglionic effects of tachycardia, hypertension.
         LD 50  or LCT 50 : The amount of solid, liquid, or vapor sufficient to kill the average person.
         Persistent, last longer than 24 hours; nonpersistent, gone in 24 hours or less

         Tabun (GA), Sarin (GB), Soman (GD), G, and VX
         S/Sx: Mild to moderate vapor exposure S/Sx: CNS-slowness in thinking and decision making. HEENT-miosis, blurred
         or dim vision, rhinorrhea, salivation. Respiratory-SOB, chest tightness.
         Large vapor exposure S/Sx: CNS-LOC, seizures, flaccid paralysis. Respiratory-apnea GI-involuntary NVD, abdominal
         pain.
         Liquid on skin exposure: Small-local effects such as sweating and fasciculations. Medium-systemic effects, potential
         miosis. Large – CNS and respiratory effects such as respiratory failure, LOC, seizures, apnea, flaccid paralysis, miosis
         MANAGEMENT: 1 × ATNAA for any patient with miosis. Mild-1 × ATNAA (self-aid) or 3 ×  ATNAA (buddy-aid). Moderate/
         Severe-3 × ATNAA plus 1 × CANA injector even if seizure activity is not evident. Atropine 6mg IM or 8mg IV/IO should
         be repeated q 3–5 mins until the drying of secretions is noted. One additional dose of 2 PAM CL should be given 1 hour
         after the initial 3 doses if patient is still symptomatic.
         Severe nerve agent casualties may need more than 2–3 CANA auto injectors to relieve seizure activity.
         DISPOSITION: Refer to chemical casualty triage table
         SPECIAL CONSIDERATIONS: Heart rate should not be a distinguishing sign due to its ability to be normal, tachycardia,
         or bradycardia. Once removed from exposure vapor nerve agent effects do not worsen.
         Packaging: The Antidote Treatment Nerve Agent Auto injector (ATNAA) (NSN: 6505-01-362-7427) is an auto injector
         with 2mg of atropine and 600mg of 2PAM CL combined.
         The Convulsant Antidote for Nerve Agents (CANA) (NSN: 6505-01-274-0951) contains 10mg of diazepam.






















        78      SECTION 2   PRIMARY TRAUMA PROTOCOLS
   87   88   89   90   91   92   93   94   95   96   97